Local Institution

Oxford, Oxfordshire OX3 7LJ

0 studies enrolling now · 6 studies all time

What they study most

Leukemia, Pediatric, Melanoma, Non-small Cell Lung Cancer, Ulcerative Colitis, Unresectable or Metastatic Melanoma

Studies at this site

• A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma — Completed
• A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) — Completed
• Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia — Completed
• An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma — Completed
• A Study of Abatacept in Patients With Active Ulcerative Colitis — Completed
• Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) — Stopped early